Literature DB >> 8009847

Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.

J L Martinez-Torrecuadrada1, H Iwata, A Venteo, I Casal, P Roy.   

Abstract

African horsesickness virus (AHSV) is a gnat-transmitted member of the Orbivirus genus of the Reoviridae family. The virus has a genome of 10 double-stranded RNA species (L1-L3, M4-M6, S7-S10). The L2 and M6 genes of AHSV serotype 4 (AHSV-4) which encode the outer capsid proteins VP2 and VP5, respectively, were inserted into recombinant baculoviruses downstream of the baculovirus polyhedrin, or p10 promoters. Recombinant baculoviruses expressing VP2, VP5, or VP2 and VP5 proteins of AHSV-4 were isolated. The expressed AHSV proteins were similar in size and antigenic properties to those of viral AHSV-4. Expressed VP2 and VP5 proteins were purified to homogeneity and utilized to differentiate sera from vaccinated and infected horses. Antigens were also used to determine whether any other AHSV serotypes are related to AHSV-4. The results indicated that AHSV-4 is distantly related to some serotypes (e.g., AHSV-2, -6, and -9) but not to others (e.g., AHSV-5 and -7). Hyperimmune monospecific antisera raised in rabbits with purified VP2 neutralized the infectivity of a virulent strain of AHSV-4 isolated from an infected horse during a recent outbreak of the disease in Spain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8009847     DOI: 10.1006/viro.1994.1351

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Serologic markers in early stages of African horse sickness virus infection.

Authors:  J L Martínez-Torrecuadrada; M Díaz-Laviada; P Roy; C Sánchez; C Vela; J M Sánchez-Vizcaíno; J I Casal
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

2.  Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.

Authors:  René G P van Gennip; Sandra G P van de Water; Christiaan A Potgieter; Piet A van Rijn
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Antigenic properties and diagnostic potential of baculovirus-expressed infectious bursal disease virus proteins VPX and VP3.

Authors:  J L Martínez-Torrecuadrada; B Lázaro; J F Rodriguez; J I Casal
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

4.  Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.

Authors:  Yuta Kanai; Piet A van Rijn; Mieke Maris-Veldhuis; Yuki Kaname; T N Athmaram; Polly Roy
Journal:  Vaccine       Date:  2014-07-18       Impact factor: 3.641

5.  Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan.

Authors:  Siham T Karamalla; Ahmed I Gubran; Ibrahim A Adam; Tamadur M Abdalla; Reem O Sinada; Eltahir M Haroun; Imadeldin E Aradaib
Journal:  BMC Vet Res       Date:  2018-08-01       Impact factor: 2.741

6.  Evidence of Intragenic Recombination in African Horse Sickness Virus.

Authors:  Harry G Ngoveni; Antoinette van Schalkwyk; J J Otto Koekemoer
Journal:  Viruses       Date:  2019-07-18       Impact factor: 5.048

Review 7.  Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Natalia Barreiro-Piñeiro; Tomás Pose-Boirazian; José Martínez-Costas; Alejandro Marín-López; Javier Ortego
Journal:  Vaccines (Basel)       Date:  2022-07-14

8.  Serotype- and serogroup-specific detection of African horsesickness virus using phage displayed chicken scFvs for indirect double antibody sandwich ELISAs.

Authors:  Wouter van Wyngaardt; Cordelia Mashau; Isabel Wright; Jeanni Fehrsen
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

9.  A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.

Authors:  Mine Aksular; Eva Calvo-Pinilla; Alejandro Marín-López; Javier Ortego; Adam C Chambers; Linda A King; Javier Castillo-Olivares
Journal:  Vaccine       Date:  2018-10-08       Impact factor: 3.641

10.  Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.

Authors:  Daria A Rutkowska; Nobalanda B Mokoena; Tsepo L Tsekoa; Vusi S Dibakwane; Martha M O'Kennedy
Journal:  BMC Vet Res       Date:  2019-12-03       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.